APA (7th ed.) Citation

Funatsu, M., Higashijima, F., Ariyoshi, N., Haraguchi, A., Wasai, Y., Mikuni, M., . . . Kimura, K. (2026). Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study. Journal of Clinical Medicine, 15(6), 2210. https://doi.org/10.3390/jcm15062210

Chicago Style (17th ed.) Citation

Funatsu, Masahiko, et al. "Switching to High-Dose Aflibercept (8 Mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study." Journal of Clinical Medicine 15, no. 6 (2026): 2210. https://doi.org/10.3390/jcm15062210.

MLA (9th ed.) Citation

Funatsu, Masahiko, et al. "Switching to High-Dose Aflibercept (8 Mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study." Journal of Clinical Medicine, vol. 15, no. 6, 2026, p. 2210, https://doi.org/10.3390/jcm15062210.